Cronos: Raymond James Reiterates Price Target After PharmaCann Investment
Yesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets is high with their strategic
Read moreYesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets is high with their strategic
Read moreIt appears that rules pertaining to ownership of US cannabis operations are loosening at the TSX Exchange and US big
Read moreMedmen Enterprises (CSE: MMEN) announced this morning that it will be terminating its merger agreement with that of PharmaCann, a
Read moreMedmen Enterprises (CSE: MMEN) announced that it is one step closer to closing its acquisition of PharmaCann LLC this morning.
Read moreIonic Brands (CSE: IONC) announced this morning that it has struck a distribution deal for its line of Zoots Premium
Read more